Results 181 to 190 of about 183,225 (358)
Assessment of Cervical Lymph Node Metastasis in Esophageal Carcinoma Using Ultrasonography [PDF]
openalex +1 more source
ABSTRACT Background In recent years, particle therapy has shown promise as a local treatment for salivary gland carcinoma (SGC); however, its efficacy and safety remain unclear. This study aimed to evaluate the clinical outcomes of intensity‐modulated proton therapy (IMPT) for SGC.
Gaku Takano+16 more
wiley +1 more source
Enlarged cervical lymph nodes two years after diagnosis of membranous glomerulonephritis [PDF]
Gregor Wolf
openalex +1 more source
ABSTRACT Background Oropharyngeal squamous cell carcinoma (SCC) can present as cancer of unknown primary, where only cervical lymph node metastases are identified. Most tumors, particularly human‐papillomavirus‐associated ones, are located in the palatine/lingual tonsils.
Sannia Sjöstedt+5 more
wiley +1 more source
ABSTRACT Background Determining whether to treat the elective cervical lymph node (LN) area remains a dilemma in maxillary sinus squamous cell carcinoma (SCC). This study analyzed the patterns of initial LN involvement and recurrence to guide treatment strategies. Methods We retrospectively reviewed 119 patients with maxillary sinus SCC treated between
Jina Kim+4 more
wiley +1 more source
Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma. [PDF]
Wei B+9 more
europepmc +1 more source
ABSTRACT Objective Oral cavity carcinomas (OCCs) represent roughly 50% of all head and neck cancers. The risk of occult neck metastases for early‐stage OCCs ranges from 15% to 35%, hence the need to develop tools that can support the diagnosis of detecting these neck metastases.
Stefania Troise+12 more
wiley +1 more source
ABSTRACT Background Adenoid cystic carcinoma (ACC) is the second most common and treatment‐resistant salivary gland carcinoma (SGC). Although platinum‐based therapies are effective, the efficacy of eribulin, a microtubule inhibitor with an 18% response rate in a Phase II trial involving recurrent/metastatic SGC, in patients with advanced ACC after ...
Tomomi Sanomachi+16 more
wiley +1 more source